Dr. Nitesh Kunda joined St. John’s University in 2018 as an Assistant Professor in Industrial Pharmacy/ Pharmaceutics in the Department of Pharmaceutical Sciences within the College of Pharmacy and Health Sciences. Prior to joining St. John’s, Dr. Kunda was a post-doctoral fellow (2015 – 2018) at the College of Pharmacy, University of New Mexico, Albuquerque, NM, with a research focus in aerosol drug and vaccine delivery. Dr. Kunda holds a Ph.D. (2014) in Formulation and Drug Delivery from the School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University in Liverpool, United Kingdom. Dr. Kunda’s dissertation focused on developing a novel pneumococcal vaccine that can be inhaled as a dry powder. Dr. Kunda holds a Master’s (2011) in Drug Delivery from the London School of Pharmacy, London, UK and a Bachelor’s (2009) in Pharmacy (Honors) from Birla Institute of Technology & Science-Pilani (BITS-Pilani), India.
Dr. Kunda’s current research interests include the use of nanotechnology in developing therapeutics against infectious disease and cancer, synthesizing polymeric nanoparticles and attaching targeting moieties for site-specific delivery, amorphous solid dispersions, and drug and vaccine formulation for pulmonary delivery. Dr. Kunda’s laboratory specializes in developing dry powder biologics that do not require cold-chain for storage and transport thereby decreasing the cost of biologics-based products significantly.
Dr. Kunda has numerous high-impact peer-reviewed research publications covering a wide variety of topics including formulation, drug delivery, stabilization of vaccines, and health effects due to common environmental toxicants. Dr. Kunda is an active member of the American Association of Pharmaceutical Scientists (AAPS, since 2012) and many other professional organizations. Dr. Kunda has been a moderator for many AAPS workshops and sessions and organized regional AAPS meeting. Dr. Kunda is currently editing a book with Springer Publishing, focusing on mucosal delivery of drugs and biologics in nanoparticles, in the AAPS Advances in the Pharmaceutical Sciences series. Further, Dr. Kunda is an editorial board member of PLoS One and a reviewer for many high-impact journals such as International Journal of Pharmaceutics, ACS Applied Materials & Interfaces, Toxicology in vitro, Human Vaccines & Immunotherapeutics, and PLoS One.
*Interested students can email Dr. Kunda for potential research opportunities.
PHS 3601 Pharmaceutics I
PHS 3603 Pharmaceutics II
2012 – American Association of Pharmaceutical Sciences (AAPS)
2017 - European Respiratory Society
2012 – 2018 The Aerosol Society
2014 – 2018 Member of Royal Society of Chemistry (MRSC)
2013 – 2015 British Society of Nanomedicine
2013 – 2014 European Society of Biomaterials
2012 – 2014 UK & Ireland Controlled Release Society
2013 – 2016 The Academy of Pharmaceutical Sciences UK
Muttil P, Wafula D, Wu T, Kunda NK, Price DN. “Vaccination Compositions, Methods of Making, and Methods of Use.” US Application Number: US 15/311,298.